期刊文献+

孕中期唐氏综合征血清学筛查预测不良妊娠结局的价值分析 被引量:8

Analysis of the Value of Serological Screening for Down’s Syndrome in the Second Trimester of Pregnancy in Predicting Adverse Pregnancy Outcomes
下载PDF
导出
摘要 目的:探析孕中期唐氏综合征血清学筛查预测不良妊娠结局的价值。方法:将2017年6月-2018年12月于笔者所在医院接受唐氏血清筛查的826例孕妇作为研究对象,均接受唐氏血清筛查,并根据筛查结果,将其分为低风险组(757例)及高风险组(69例)。比较两组唐氏综合征发生情况及不良妊娠结局。结果:高风险组唐氏综合征发生率为5.79%,高于低风险组的0,差异有统计学意义(P<0.05)。高风险组自然流产、死胎及胎盘早剥发生率均显著高于低风险组,差异有统计学意义(P<0.05)。结论:唐氏血清筛查高风险与不良妊娠结局的发生具有一定的联系,可将其视为不良妊娠结局预测的一大指标。 Objective:To explore the value of serological screening for Down’s syndrome in the second trimester of pregnancy in predicting adverse pregnancy outcomes.Method:A total of 826 pregnant women who received Down’s serum screening in our hospital from June 2017 to December 2018 were selected as the research objects,all of whom received Down’s serum screening.According to the screening results,they were divided into the low-risk group(757 cases)and high-risk group(69 cases).The incidence of Down’s syndrome and adverse pregnancy outcomes of the two groups were compared.Result:The incidence of Down’s syndrome in the high-risk group was 5.79%,which was higher than 0 in the low-risk group,and the difference was statistically significant(P<0.05).The incidence of spontaneous abortion,stillbirth and placental abruption in the high-risk group were significantly higher than those in the low-risk group,and the difference was statistically significant(P<0.05).Conclusion:The high risk of Down’s serum screening is associated with the occurrence of adverse pregnancy outcomes,which can be regarded as a major index for the prediction of adverse pregnancy outcomes.
作者 杨凤敏 YANG Fengmin(Aerospace Center Hospital,Beijing 100049,China)
机构地区 航天中心医院
出处 《中外医学研究》 2020年第20期55-56,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 孕中期 唐氏综合征 血清学筛查 不良妊娠结局 Second trimester of pregnancy Down’s syndrome Serological screening Adverse pregnancy outcomes
  • 相关文献

参考文献12

二级参考文献127

  • 1许烨烨,王威,蒋馥蔓,丛林.无创性产前基因检测胎儿Turner综合征1例并文献复习[J].中国产前诊断杂志(电子版),2012,4(2):42-45. 被引量:5
  • 2段涛,边旭明,向阳,孙路明.我国产前诊断的现状与展望[J].现代妇产科进展,2006,15(2):81-91. 被引量:55
  • 3无,胡娅莉.26 803例中期妊娠妇女血清筛查胎儿染色体异常的结果分析[J].中华医学杂志,2007,87(35):2476-2480. 被引量:21
  • 4Palomaki GE, Knight GJ, Ashwood ER, et al. Screening fordown syndrome in the United States: results of surveys in 2011and 2012[J]. Arch Pathol Lab Med, 2013, 137:921-926.
  • 5Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal screeningfor Down's syndrome with use of maternal serum markers[J]. NEngl J Med, 1992, 327:588-593.
  • 6Spencer K. Screening for Down syndrome[J]. Scand J Clin LabInvest, 2014 ,74:41-47.
  • 7Carla D, Howard C, Yuval Y. Screening for Down syndrome-incidental diagnosis of other aneuploidies[J]. Prenat Diagn,2014,34:1-5.
  • 8Palomaki GE, Lee JE, Canick JA, et al. Technical standards andguidelines: prenatal screening for Down syndrome that includesfirst-trimester biochemistry and/or ultrasound measurements[J].Genet Med,2009,11:669-681.
  • 9Chitayat D, Langlois S, Wilson RD. Prenatal screening for fetalaneuploidy in singleton pregnancies[J].J Obstet Gynaecol Can,2011,33:736-750.
  • 10左启华.智力发育迟缓的遗传学//严仁英.实用优生学.2版[M].北京:人民卫生出版社,1998:529.

共引文献131

同被引文献73

引证文献8

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部